Biogen | BIIB - 贷款资金



金融业
股票价格
USD
资产
USD 32.09B
现金及等价物
USD 1.29B
销售成本
USD 945.1M
流动资产
USD 7.31B
流动负债
USD 3.92B
债务
USD 8.09B
EBIT
USD -243.8M
EBITDA
USD 649.7M
员工
7.61K
EPS每股收益
USD 3.6
股本和储备
USD 18.85B
销售毛利
USD 2.12B
债务利息支出
USD 72.6M
利息收入
USD 37.9M
贷款资金
USD 7.29B
市值
USD 32.54B
净收入
USD 97.5M
营业费用
USD 2.98B
营业利润
USD -243.8M
普通股股本
USD 146.7M
PE价格收益
23.23
税前利润
USD 647.3M
销售收入
USD 2.74B
销售和管理费用
USD 709.7M
股票
USD 2.38B
贸易债权人
USD 403.9M
应收帐款人
USD 1.79B


贷款资金 更改 日
AbbVie USD 64.53B 5.59B 2026-03
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 1.48B 7.23M 2026-06
Amgen USD 51.86B 27M 2026-06
Bayer EUR 31.16B 480M 2026-06
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
Incyte USD 28.42M 994K 2026-06
Merck USD 51.08B 4.41B 2026-06
Moderna USD 597M 6M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
PTC Therapeutics USD 535.52M 248.58M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 14.65B 806M 2026-06
Sanofi EUR 12.3B 3.42B 2026-03
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Teva Pharmaceutical Industries USD 12.09B 1.92B 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12